Gamunex
Commercial- Indications
- CIDP, Primary immune deficiencies, Idiopathic thrombocytopenic purpura
Company intelligence / Profile preview
International BioResources (IBR) is not a drug development company. Its business is focused on sourcing and supplying human plasma to other biotechnology and pharmaceutical firms for downstream manufacturing. It has no proprietary clinical programs or internal drug pipeline.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International BioResources.